EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study

Harshavardhani Canchi Sistla, Arun Seshachalam, Krishna Kumar Rathnam, Taruna Rajagopal, Srikanth Talluri, Sivaramakrishnan Venkatabalasubramanian, Nageswara Rao Dunna

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-13003-2 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Harshavardhani Canchi Sistla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genomics & Molecular Oncology Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjav…. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 1, Receptor, Fibroblast Growth Factor, Type 2, Ovarian Neoplasms, Vascular Endothelial Growth Factor A. Die Arbeit nennt 37 Literaturangaben. Gefördert von: SASTRA University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ovarian cancer (OC) is a genetically heterogeneous malignancy characterized by marked molecular and histologic heterogeneity. Genetic variation in pathways involved in angiogenesis and extracellular matrix remodeling may contribute to OC susceptibility. The present study evaluated VEGFA rs833061, FGFR2 rs1219648, and MMP1 rs1799750 polymorphisms in a South Indian cohort and investigated their individual and combined associations with OC risk. METHODS: This hospital-based pilot case-control study included 240 histopathologically confirmed OC cases and 254 cancer-free controls. Genotyping was performed using PCR-RFLP and allele-specific PCR. Associations with OC susceptibility were assessed using logistic regression with adjustment for age and menopausal status, with the codominant model as the primary genetic model and alternative models as secondary analyses. Exploratory clinicopathological and multifactor dimensionality reduction (MDR) analyses were also performed. RESULTS: MMP1 rs1799750 was associated with increased OC susceptibility, with the 2G/2G genotype showing higher odds of OC (aOR = 2.10, 95% CI = 1.12-3.94; p = 0.0179). Similarly, VEGFA rs833061 was also associated with increased susceptibility, with T/C and C/C genotypes showing higher odds (aOR = 2.51, 95% CI = 1.55-4.06; p = < 0.001 and aOR = 1.87, 95% CI = 1.04-3.35; p = 0.021, respectively). However, FGFR2 rs1219648 was not associated with overall OC susceptibility but showed exploratory associations with selected clinicopathological characteristics. The two-locus VEGFA-MMP1 MDR model showed the highest testing balanced accuracy among evaluated models (TBA = 0.5853; CVC = 10/10). CONCLUSION: VEGFA and MMP1 variants showed associations with OC susceptibility in this South Indian cohort. Combined-genotype and MDR findings are hypothesis-generating and require validation in larger, independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 1Receptor, Fibroblast Growth Factor, Type 2Ovarian NeoplasmsVascular Endothelial Growth Factor AHumansFemaleCase-Control StudiesGenetic Predisposition to DiseaseIndiaPolymorphism, Single NucleotideMiddle AgedGenotypeAdultSouth Asian PeopleAgedGene FrequencyPilot Projects

Stichwörter der Autor:innen

AngiogenesisExtracellular matrixGenetic associationOvarian cancerPolymorphismsSouth Asian populationVariants

Substanzen

Matrix Metalloproteinase 1Receptor, Fibroblast Growth Factor, Type 2Vascular Endothelial Growth Factor AFGFR2 protein, humanMMP1 protein, humanVEGFA protein, human

Autor:innen und Institutionen

  • Cancer Genomics & Molecular Oncology Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, 613 401, India.
  • Department of Medical and Paediatric Oncology, Dr. G.V.N Cancer Institute, Riverside, Trichy, 620 005, India.
  • Department of Hemato Oncology - Medical Oncology and Bone Marrow Transplantation, Meenakshi Mission Hospital & Research Centre, Madurai, 625 107, India.
  • Department of Biotechnology, Sona College of Arts and Science, Salem, 636 005, India.
  • Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, 603 203, India.

Förderung

  • SASTRA University

Zitieren

APA

Canchi Sistla, H., Seshachalam, A., Rathnam, K. K., Rajagopal, T., Talluri, S., Venkatabalasubramanian, S., & Dunna, N. R. (2026). Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-13003-2

Vancouver

Canchi Sistla H, Seshachalam A, Rathnam KK, Rajagopal T, Talluri S, Venkatabalasubramanian S, et al. Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-13003-2

BibTeX
@article{CanchiSistla2026,
  author = {Canchi Sistla, Harshavardhani and Seshachalam, Arun and Rathnam, Krishna Kumar and Rajagopal, Taruna and Talluri, Srikanth and Venkatabalasubramanian, Sivaramakrishnan and Dunna, Nageswara Rao},
  title = {Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-13003-2}
}
Kostenlos starten →